IL13 and neoplasm: Mouse cells express a soluble form of IL13Rα2, which might interfere with the antibody to deplete extracellular IL-13, as secreted IL13Rα2 may bind the antibody in the circulation and could prevent sufficient antibody from binding to the tumor.